CCAPCrescent Capital BDC, Inc.
What is the market doing?
In a downtrend (−24% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 18). Price is −24% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CCAP is trading
Crescent Capital BDC, Inc. is −30% over the past year while the S&P 500 is +18%: 48 points behind the market. Through the fall, its own insiders bought $1.1M more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −24%
vs 200-day average · a clear downtrend
- RSI (14)
- 18
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-08
- $9.10
- 1 monthS&P 500 +1.6%
- −11%
- 1 yearS&P 500 +18%
- −30%
- 5 yearsS&P 500 +86%
- −20%
- vs 50-day average$10.32
- −12%
- 52-week high
- $14.31
- 52-week low
- $9.02
- Annualised volatility
- 25%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $1.1M
| Year | Return |
|---|---|
| 2026 (year to date) | −33% |
| 2025 | −18% |
| 2024 | +24% |
| 2023 | +53% |
| 2022 | −18% |
| 2021 | +32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 5 of 6 | +4.6% |
| Feb | 6 | 3 of 6 | −1.4% |
| Mar | 7 | 3 of 7 | −5.2% |
| Apr | 7 | 5 of 7 | +2.5% |
| May | 7 | 3 of 7 | +0.94% |
| Jun | 7 | 4 of 7 | +1.7% |
| Jul | 7 | 5 of 7 | +1.4% |
| Aug | 7 | 4 of 7 | +2.2% |
| Sep | 7 | 4 of 7 | −1.4% |
| Oct | 7 | 2 of 7 | −2.1% |
| Nov | 6 | 5 of 6 | +3.1% |
| Dec | 6 | 4 of 6 | +1.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Asset Management
The closest names by size in the same industry